Sep 28, 2026 07:04AM
Sep 25, 2026 07:02AM
Sep 10, 2026 06:57AM
Aug 6, 2026 07:53AM
Jul 29, 2026 07:03AM
Jul 13, 2026 07:03AM
May 27, 2026 06:55AM Ocugen, Inc. (OCGN) PT Lowered to $11 at Canaccord
May 14, 2026 04:41PM
May 5, 2026 08:42AM
May 5, 2026 08:34AM
Mar 25, 2026 09:22AM
Mar 25, 2026 06:55AM
Mar 11, 2026 06:03AM
Mar 4, 2026 08:19AM Ocugen (OCGN) Reports In-Line Q4 EPS
Mar 4, 2026 08:15AM
Sep 30, 2025 06:05AM
Sep 18, 2025 11:02AM
Aug 13, 2025 06:27AM
Aug 1, 2025 08:33AM
Jul 21, 2025 07:30AM
Jun 24, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Ocugen, Inc. (OCGN)
Jun 23, 2025 07:30AM
Jun 16, 2025 07:03AM
Jun 5, 2025 10:32AM
Jun 5, 2025 07:03AM
May 27, 2025 07:04AM
May 13, 2025 06:59AM
May 9, 2025 08:22AM Ocugen (OCGN) Tops Q1 EPS by 1c
Mar 18, 2025 08:06AM
Mar 5, 2025 07:14AM
Mar 3, 2025 09:01AM
Feb 27, 2025 08:48AM
Feb 13, 2025 06:50AM
Feb 12, 2025 07:45AM
Feb 3, 2025 06:31AM Ocugen (OCGN) Announces Positive Opinion of European Medicines Agency’s Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for OCU400
Jan 27, 2025 06:31AM
Jan 13, 2025 06:31AM
Dec 19, 2024 06:40AM
Nov 20, 2024 07:33AM
Nov 19, 2024 07:03AM
Nov 8, 2024 06:53AM
Oct 22, 2024 07:02AM Ocugen (OCGN) Reports Data and Safety Monitoring Board Approves Initiation of Phase 2 of OCU410ST GARDian Clinical Trial for Stargardt Disease
Oct 15, 2024 08:18AM
Oct 9, 2024 06:33AM
Aug 28, 2024 06:32AM
Aug 26, 2024 07:03AM
Aug 8, 2024 07:11AM
Aug 5, 2024 06:31AM
Aug 1, 2024 06:23AM Ocugen (OCGN) Prices 30.43M Share Offering at $1.15/sh
Jul 31, 2024 04:15PM

468,930 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All